Střevní mikrobiom a jeho změny ve vztahu k léčbě chronických onemocnění

• Název práce v češtině: Střevní mikrobiom a jeho změny ve vztahu k léčbě chronických onemocnění
• Název v anglickém jazyce: Gut microbiome and its changes related to therapy of chronic diseases
• Klíčová slova: mikrobiom, Crohnova choroba, celiakie, syndrom dráždivého tračníku
• Klíčová slova anglicky: microbiome, Crohn's disease, celiac disease, irritable bowel syndrome
• Akademický rok vypsání: 2018/2019
• Typ práce: disertační práce
• Jazyk práce: čeština
• Ústav: Pediatrická klinika (13-350)
• Vedoucí / školitel: prof. MUDr. Ondřej Cinek, Ph.D.
• Řešitel: skrytý - zadáno vedoucím/školitelem
• Datum přihlášení: 04.10.2018
• Datum zadání: 04.10.2018
• Datum a čas obhajoby: 28.03.2024 09:30
• Datum odevzdání elektronické podoby: 22.02.2024
• Datum odevzdání tištěné podoby: 22.02.2024
• Datum proběhlé obhajoby: 28.03.2024
• Oponenti: prof. MUDr. Milan Kolář, Ph.D.

Seznam odborné literatury

Použitá literatura
Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., & Versalovic, J. (2014). The placenta harbors a unique microbiome. Sci Transl Med, 6(237), 237ra265. https://doi.org/10.1126/scitranslmed.3008599
Abubucker, S., Segata, N., Goll, J., Schubert, A. M., Izard, J., Cantarel, B. L., Rodriguez-Mueller, B., Zucker, J., Thiagarajan, M., Henrissat, B., White, O., Kelley, S. T., Methe, B., Schloss, P. D., Gevers, D., Mitreva, M., & Huttenhower, C. (2012). Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol, 8(6), e1002358. https://doi.org/10.1371/journal.pcbi.1002358
Alfellani, M. A., Stensvold, C. R., Vidal-Lapiedra, A., Onuoha, E. S., Fagbenro-Beyioku, A. F., & Clark, C. G. (2013). Variable geographic distribution of Blastocystis subtypes and its potential implications. Acta Trop, 126(1), 11-18. https://doi.org/S0001-706X(12)00399-3 [pii]
10.1016/j.actatropica.2012.12.011
Ananthakrishnan, A. N., Luo, C., Yajnik, V., Khalili, H., Garber, J. J., Stevens, B. W., Cleland, T., & Xavier, R. J. (2017). Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases. Cell Host Microbe, 21(5), 603-610 e603. https://doi.org/10.1016/j.chom.2017.04.010
Andersen, L. O., Bonde, I., Nielsen, H. B., & Stensvold, C. R. (2015). A retrospective metagenomics approach to studying Blastocystis. FEMS Microbiol Ecol, 91(7). https://doi.org/10.1093/femsec/fiv072
Andersen, L. O., & Stensvold, C. R. (2016). Blastocystis in Health and Disease: Are We Moving from a Clinical to a Public Health Perspective? J Clin Microbiol, 54(3), 524-528. https://doi.org/10.1128/JCM.02520-15
Andren Aronsson, C., Lee, H. S., Hard Af Segerstad, E. M., Uusitalo, U., Yang, J., Koletzko, S., Liu, E., Kurppa, K., Bingley, P. J., Toppari, J., Ziegler, A. G., She, J. X., Hagopian, W. A., Rewers, M., Akolkar, B., Krischer, J. P., Virtanen, S. M., Norris, J. M., Agardh, D., & Group, T. S. (2019). Association of Gluten Intake During the First 5 Years of Life With Incidence of Celiac Disease Autoimmunity and Celiac Disease Among Children at Increased Risk. JAMA, 322(6), 514-523. https://doi.org/10.1001/jama.2019.10329
Aroniadis, O. C., Brandt, L. J., Oneto, C., Feuerstadt, P., Sherman, A., Wolkoff, A. W., Kassam, Z., Sadovsky, R. G., Elliott, R. J., Budree, S., Kim, M., & Keller, M. J. (2019). Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol, 4(9), 675-685. https://doi.org/10.1016/S2468-1253(19)30198-0
Arvonen, M., Vahasalo, P., Turunen, S., Salo, H. M., Maki, M., Laurila, K., Vaarala, O., & Karttunen, T. J. (2012). Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis. Clin Exp Immunol, 170(3), 266-273. https://doi.org/10.1111/j.1365-2249.2012.04663.x
Audebert, C., Even, G., Cian, A., Blastocystis Investigation, G., Loywick, A., Merlin, S., Viscogliosi, E., & Chabe, M. (2016). Colonization with the enteric protozoa Blastocystis is associated with increased diversity of human gut bacterial microbiota. Sci Rep, 6, 25255. https://doi.org/10.1038/srep25255
Backhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., Khan, M. T., Zhang, J., Li, J., Xiao, L., Al-Aama, J., Zhang, D., Lee, Y. S., Kotowska, D., Colding, C., . . . Wang, J. (2015). Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host Microbe, 17(5), 690-703. https://doi.org/10.1016/j.chom.2015.04.004
Bach, J. F. (2001). Protective role of infections and vaccinations on autoimmune diseases. J Autoimmun, 16(3), 347-353. https://doi.org/10.1006/jaut.2000.0478
Barcenilla, A., Pryde, S. E., Martin, J. C., Duncan, S. H., Stewart, C. S., Henderson, C., & Flint, H. J. (2000). Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol, 66(4), 1654-1661. https://doi.org/10.1128/AEM.66.4.1654-1661.2000
Barnich, N., & Darfeuille-Michaud, A. (2007). Adherent-invasive Escherichia coli and Crohn's disease. Curr Opin Gastroenterol, 23(1), 16-20. https://doi.org/10.1097/MOG.0b013e3280105a38
Barratt, J. L., Harkness, J., Marriott, D., Ellis, J. T., & Stark, D. (2011). A review of Dientamoeba fragilis carriage in humans: several reasons why this organism should be considered in the diagnosis of gastrointestinal illness. Gut Microbes, 2(1), 3-12. https://doi.org/10.4161/gmic.2.1.14755
Barrett, J. S., Gearry, R. B., Muir, J. G., Irving, P. M., Rose, R., Rosella, O., Haines, M. L., Shepherd, S. J., & Gibson, P. R. (2010). Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther, 31(8), 874-882. https://doi.org/10.1111/j.1365-2036.2010.04237.x
Barry, M. A., Weatherhead, J. E., Hotez, P. J., & Woc-Colburn, L. (2013). Childhood parasitic infections endemic to the United States. Pediatr Clin North Am, 60(2), 471-485. https://doi.org/10.1016/j.pcl.2012.12.011
Bart, A., Wentink-Bonnema, E. M., Gilis, H., Verhaar, N., Wassenaar, C. J., van Vugt, M., Goorhuis, A., & van Gool, T. (2013). Diagnosis and subtype analysis of Blastocystis sp. in 442 patients in a hospital setting in the Netherlands. BMC Infect Dis, 13, 389. https://doi.org/10.1186/1471-2334-13-389
Baunwall, S. M. D., Lee, M. M., Eriksen, M. K., Mullish, B. H., Marchesi, J. R., Dahlerup, J. F., & Hvas, C. L. (2020). Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis. EClinicalMedicine, 29-30, 100642. https://doi.org/10.1016/j.eclinm.2020.100642
Belkaid, Y., & Hand, T. W. (2014). Role of the microbiota in immunity and inflammation. Cell, 157(1), 121-141. https://doi.org/10.1016/j.cell.2014.03.011
Berg, G., Rybakova, D., Fischer, D., Cernava, T., Verges, M. C., Charles, T., Chen, X., Cocolin, L., Eversole, K., Corral, G. H., Kazou, M., Kinkel, L., Lange, L., Lima, N., Loy, A., Macklin, J. A., Maguin, E., Mauchline, T., McClure, R., . . . Schloter, M. (2020). Microbiome definition re-visited: old concepts and new challenges. Microbiome, 8(1), 103. https://doi.org/10.1186/s40168-020-00875-0
Bjerrum, J. T., Wang, Y., Hao, F., Coskun, M., Ludwig, C., Gunther, U., & Nielsen, O. H. (2015). Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics, 11, 122-133. https://doi.org/10.1007/s11306-014-0677-3
Blais Lecours, P., Marsolais, D., Cormier, Y., Berberi, M., Hache, C., Bourdages, R., & Duchaine, C. (2014). Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseases. PLoS One, 9(2), e87734. https://doi.org/10.1371/journal.pone.0087734
Blaser, M. J., & Falkow, S. (2009). What are the consequences of the disappearing human microbiota? Nat Rev Microbiol, 7(12), 887-894. https://doi.org/10.1038/nrmicro2245
Bodkhe, R., Shetty, S. A., Dhotre, D. P., Verma, A. K., Bhatia, K., Mishra, A., Kaur, G., Pande, P., Bangarusamy, D. K., Santosh, B. P., Perumal, R. C., Ahuja, V., Shouche, Y. S., & Makharia, G. K. (2019). Comparison of Small Gut and Whole Gut Microbiota of First-Degree Relatives With Adult Celiac Disease Patients and Controls. Front Microbiol, 10, 164. https://doi.org/10.3389/fmicb.2019.00164
Bokulich, N. A., Chung, J., Battaglia, T., Henderson, N., Jay, M., Li, H., A, D. L., Wu, F., Perez-Perez, G. I., Chen, Y., Schweizer, W., Zheng, X., Contreras, M., Dominguez-Bello, M. G., & Blaser, M. J. (2016). Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med, 8(343), 343ra382. https://doi.org/10.1126/scitranslmed.aad7121
Bonnet, R., Suau, A., Dore, J., Gibson, G. R., & Collins, M. D. (2002). Differences in rDNA libraries of faecal bacteria derived from 10- and 25-cycle PCRs. Int J Syst Evol Microbiol, 52(Pt 3), 757-763. https://doi.org/10.1099/00207713-52-3-757
Brugere, J. F., Borrel, G., Gaci, N., Tottey, W., O'Toole, P. W., & Malpuech-Brugere, C. (2014). Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease. Gut Microbes, 5(1), 5-10. https://doi.org/10.4161/gmic.26749
Bruijnesteijn van Coppenraet, L. E., Dullaert-de Boer, M., Ruijs, G. J., van der Reijden, W. A., van der Zanden, A. G., Weel, J. F., & Schuurs, T. A. (2015). Case-control comparison of bacterial and protozoan microorganisms associated with gastroenteritis: application of molecular detection. Clin Microbiol Infect, 21(6), 592 e599-519. https://doi.org/10.1016/j.cmi.2015.02.007
Buffie, C. G., & Pamer, E. G. (2013). Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol, 13(11), 790-801. https://doi.org/10.1038/nri3535
Buford, T. W. (2017). (Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease. Microbiome, 5(1), 80. https://doi.org/10.1186/s40168-017-0296-0
Buono, J. L., Carson, R. T., & Flores, N. M. (2017). Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes, 15(1), 35. https://doi.org/10.1186/s12955-017-0611-2
Cai, M., Kandalai, S., Tang, X., & Zheng, Q. (2022). Contributions of Human-Associated Archaeal Metabolites to Tumor Microenvironment and Carcinogenesis. Microbiol Spectr, 10(2), e0236721. https://doi.org/10.1128/spectrum.02367-21
Calderon de la Barca, A. M., Castillo-Fimbres, R. S., Mejia-Leon, M. E., Quihui-Cota, L., Ochoa-Leyva, A., & Aguayo-Patron, S. V. (2020). Enteric parasitic infection disturbs bacterial structure in Mexican children with autoantibodies for type 1 diabetes and/or celiac disease. Gut Pathog, 12, 37. https://doi.org/10.1186/s13099-020-00376-3
Cammarota, G., Ianiro, G., Kelly, C. R., Mullish, B. H., Allegretti, J. R., Kassam, Z., Putignani, L., Fischer, M., Keller, J. J., Costello, S. P., Sokol, H., Kump, P., Satokari, R., Kahn, S. A., Kao, D., Arkkila, P., Kuijper, E. J., Vehreschild, M. J. G., Pintus, C., . . . Gasbarrini, A. (2019). International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut, 68(12), 2111-2121. https://doi.org/10.1136/gutjnl-2019-319548
Canfora, E. E., Meex, R. C. R., Venema, K., & Blaak, E. E. (2019). Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol, 15(5), 261-273. https://doi.org/10.1038/s41574-019-0156-z
Cao, Z., Sugimura, N., Burgermeister, E., Ebert, M. P., Zuo, T., & Lan, P. (2022). The gut virome: A new microbiome component in health and disease. EBioMedicine, 81, 104113. https://doi.org/10.1016/j.ebiom.2022.104113
Carlier, J. P., Bedora-Faure, M., K'Ouas, G., Alauzet, C., & Mory, F. (2010). Proposal to unify Clostridium orbiscindens Winter et al. 1991 and Eubacterium plautii (Seguin 1928) Hofstad and Aasjord 1982, with description of Flavonifractor plautii gen. nov., comb. nov., and reassignment of Bacteroides capillosus to Pseudoflavonifractor capillosus gen. nov., comb. nov. Int J Syst Evol Microbiol, 60(Pt 3), 585-590. https://doi.org/10.1099/ijs.0.016725-0
Carroccio, A., Iacono, G., Cottone, M., Di Prima, L., Cartabellotta, F., Cavataio, F., Scalici, C., Montalto, G., Di Fede, G., Rini, G., Notarbartolo, A., & Averna, M. R. (2003). Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. Clin Chem, 49(6 Pt 1), 861-867. https://doi.org/10.1373/49.6.861
Carroll, I. M., Ringel-Kulka, T., Siddle, J. P., & Ringel, Y. (2012). Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil, 24(6), 521-530, e248. https://doi.org/10.1111/j.1365-2982.2012.01891.x
Cepko, L. C. S., Garling, E. E., Dinsdale, M. J., Scott, W. P., Bandy, L., Nice, T., Faber-Hammond, J., & Mellies, J. L. (2020). Myoviridae phage PDX kills enteroaggregative Escherichia coli without human microbiome dysbiosis. J Med Microbiol, 69(2), 309-323. https://doi.org/10.1099/jmm.0.001162
Cinek, O., Polackova, K., Odeh, R., Alassaf, A., Kramna, L., Ibekwe, M. U., Majaliwa, E. S., Ahmadov, G., Elmahi, B. M. E., Mekki, H., Oikarinen, S., Lebl, J., & Abdullah, M. A. (2021). Blastocystis in the faeces of children from six distant countries: prevalence, quantity, subtypes and the relation to the gut bacteriome. Parasit Vectors, 14(1), 399. https://doi.org/10.1186/s13071-021-04859-3
Clark, C. G., van der Giezen, M., Alfellani, M. A., & Stensvold, C. R. (2013). Recent developments in Blastocystis research. Adv Parasitol, 82, 1-32. https://doi.org/B978-0-12-407706-5.00001-0 [pii]
10.1016/B978-0-12-407706-5.00001-0
Clooney, A. G., Eckenberger, J., Laserna-Mendieta, E., Sexton, K. A., Bernstein, M. T., Vagianos, K., Sargent, M., Ryan, F. J., Moran, C., Sheehan, D., Sleator, R. D., Targownik, L. E., Bernstein, C. N., Shanahan, F., & Claesson, M. J. (2021). Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study. Gut, 70(3), 499-510. https://doi.org/10.1136/gutjnl-2020-321106
Cold, F., Baunwall, S. M. D., Dahlerup, J. F., Petersen, A. M., Hvas, C. L., & Hansen, L. H. (2021). Systematic review with meta-analysis: encapsulated faecal microbiota transplantation - evidence for clinical efficacy. Therap Adv Gastroenterol, 14, 17562848211041004. https://doi.org/10.1177/17562848211041004
Collado, M. C., Donat, E., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2009). Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol, 62(3), 264-269. https://doi.org/10.1136/jcp.2008.061366
Costello, S. P., Soo, W., Bryant, R. V., Jairath, V., Hart, A. L., & Andrews, J. M. (2017). Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment Pharmacol Ther, 46(3), 213-224. https://doi.org/10.1111/apt.14173
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., Biddinger, S. B., Dutton, R. J., & Turnbaugh, P. J. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature, 505(7484), 559-563. https://doi.org/10.1038/nature12820
de Wit, M. A., Koopmans, M. P., Kortbeek, L. M., van Leeuwen, N. J., Vinje, J., & van Duynhoven, Y. T. (2001). Etiology of gastroenteritis in sentinel general practices in the netherlands. Clin Infect Dis, 33(3), 280-288. https://doi.org/10.1086/321875
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004). Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol, 54(Pt 5), 1469-1476. https://doi.org/10.1099/ijs.0.02873-0
Di Biase, A. R., Marasco, G., Ravaioli, F., Dajti, E., Colecchia, L., Righi, B., D'Amico, V., Festi, D., Iughetti, L., & Colecchia, A. (2021). Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study. J Gastroenterol Hepatol, 36(2), 446-454. https://doi.org/10.1111/jgh.15183
Diether, N. E., & Willing, B. P. (2019). Microbial Fermentation of Dietary Protein: An Important Factor in Diet(-)Microbe(-)Host Interaction. Microorganisms, 7(1). https://doi.org/10.3390/microorganisms7010019
DiGiulio, D. B., Romero, R., Kusanovic, J. P., Gomez, R., Kim, C. J., Seok, K. S., Gotsch, F., Mazaki-Tovi, S., Vaisbuch, E., Sanders, K., Bik, E. M., Chaiworapongsa, T., Oyarzun, E., & Relman, D. A. (2010). Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol, 64(1), 38-57. https://doi.org/10.1111/j.1600-0897.2010.00830.x
Domingo, M. C., Huletsky, A., Boissinot, M., Bernard, K. A., Picard, F. J., & Bergeron, M. G. (2008). Ruminococcus gauvreauii sp. nov., a glycopeptide-resistant species isolated from a human faecal specimen. Int J Syst Evol Microbiol, 58(Pt 6), 1393-1397. https://doi.org/10.1099/ijs.0.65259-0
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., & Knight, R. (2010). Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A, 107(26), 11971-11975. https://doi.org/10.1073/pnas.1002601107
Donaldson, G. P., Lee, S. M., & Mazmanian, S. K. (2016). Gut biogeography of the bacterial microbiota. Nat Rev Microbiol, 14(1), 20-32. https://doi.org/10.1038/nrmicro3552
Donnachie, E., Schneider, A., Mehring, M., & Enck, P. (2018). Incidence of irritable bowel syndrome and chronic fatigue following GI infection: a population-level study using routinely collected claims data. Gut, 67(6), 1078-1086. https://doi.org/10.1136/gutjnl-2017-313713
Draper, L. A., Ryan, F. J., Dalmasso, M., Casey, P. G., McCann, A., Velayudhan, V., Ross, R. P., & Hill, C. (2020). Autochthonous faecal viral transfer (FVT) impacts the murine microbiome after antibiotic perturbation. BMC Biol, 18(1), 173. https://doi.org/10.1186/s12915-020-00906-0
Dridi, B., Henry, M., El Khechine, A., Raoult, D., & Drancourt, M. (2009). High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One, 4(9), e7063. https://doi.org/10.1371/journal.pone.0007063
Duan, Y., Llorente, C., Lang, S., Brandl, K., Chu, H., Jiang, L., White, R. C., Clarke, T. H., Nguyen, K., Torralba, M., Shao, Y., Liu, J., Hernandez-Morales, A., Lessor, L., Rahman, I. R., Miyamoto, Y., Ly, M., Gao, B., Sun, W., . . . Schnabl, B. (2019). Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature, 575(7783), 505-511. https://doi.org/10.1038/s41586-019-1742-x
Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., Sokol, H., Coffin, B., & Sabate, J. M. (2012). Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil, 24(6), 513-520, e246-517. https://doi.org/10.1111/j.1365-2982.2012.01893.x
Durban, A., Abellan, J. J., Jimenez-Hernandez, N., Salgado, P., Ponce, M., Ponce, J., Garrigues, V., Latorre, A., & Moya, A. (2012). Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome. Environ Microbiol Rep, 4(2), 242-247. https://doi.org/10.1111/j.1758-2229.2012.00327.x
Dutilh, B. E., Cassman, N., McNair, K., Sanchez, S. E., Silva, G. G., Boling, L., Barr, J. J., Speth, D. R., Seguritan, V., Aziz, R. K., Felts, B., Dinsdale, E. A., Mokili, J. L., & Edwards, R. A. (2014). A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes. Nat Commun, 5, 4498. https://doi.org/10.1038/ncomms5498
Dziarski, R., Park, S. Y., Kashyap, D. R., Dowd, S. E., & Gupta, D. (2016). Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice. PLoS One, 11(1), e0146162. https://doi.org/10.1371/journal.pone.0146162
Edwards, R. A., Vega, A. A., Norman, H. M., Ohaeri, M., Levi, K., Dinsdale, E. A., Cinek, O., Aziz, R. K., McNair, K., Barr, J. J., Bibby, K., Brouns, S. J. J., Cazares, A., de Jonge, P. A., Desnues, C., Diaz Munoz, S. L., Fineran, P. C., Kurilshikov, A., Lavigne, R., . . . Dutilh, B. E. (2019). Global phylogeography and ancient evolution of the widespread human gut virus crAssphage. Nat Microbiol, 4(10), 1727-1736. https://doi.org/10.1038/s41564-019-0494-6
El-Salhy, M., Hatlebakk, J. G., Gilja, O. H., Brathen Kristoffersen, A., & Hausken, T. (2020). Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut, 69(5), 859-867. https://doi.org/10.1136/gutjnl-2019-319630
El-Salhy, M., Hausken, T., & Hatlebakk, J. G. (2021). Current status of fecal microbiota transplantation for irritable bowel syndrome. Neurogastroenterol Motil, 33(11), e14157. https://doi.org/10.1111/nmo.14157
El Safadi, D., Cian, A., Nourrisson, C., Pereira, B., Morelle, C., Bastien, P., Bellanger, A. P., Botterel, F., Candolfi, E., Desoubeaux, G., Lachaud, L., Morio, F., Pomares, C., Rabodonirina, M., Wawrzyniak, I., Delbac, F., Gantois, N., Certad, G., Delhaes, L., . . . Viscogliosi, E. (2016). Prevalence, risk factors for infection and subtype distribution of the intestinal parasite Blastocystis sp. from a large-scale multi-center study in France. BMC Infect Dis, 16(1), 451. https://doi.org/10.1186/s12879-016-1776-8
El Safadi, D., Gaayeb, L., Meloni, D., Cian, A., Poirier, P., Wawrzyniak, I., Delbac, F., Dabboussi, F., Delhaes, L., Seck, M., Hamze, M., Riveau, G., & Viscogliosi, E. (2014). Children of Senegal River Basin show the highest prevalence of Blastocystis sp. ever observed worldwide. BMC Infect Dis, 14, 164. https://doi.org/10.1186/1471-2334-14-164
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., de Vos, W. M., & Cani, P. D. (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A, 110(22), 9066-9071. https://doi.org/10.1073/pnas.1219451110
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., Tito, R. Y., Chaffron, S., Rymenans, L., Verspecht, C., De Sutter, L., Lima-Mendez, G., D'Hoe, K., Jonckheere, K., Homola, D., . . . Raes, J. (2016). Population-level analysis of gut microbiome variation. Science, 352(6285), 560-564. https://doi.org/10.1126/science.aad3503
Finlay, B. B., Amato, K. R., Azad, M., Blaser, M. J., Bosch, T. C. G., Chu, H., Dominguez-Bello, M. G., Ehrlich, S. D., Elinav, E., Geva-Zatorsky, N., Gros, P., Guillemin, K., Keck, F., Korem, T., McFall-Ngai, M. J., Melby, M. K., Nichter, M., Pettersson, S., Poinar, H., . . . Giles-Vernick, T. (2021). The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome. Proc Natl Acad Sci U S A, 118(6). https://doi.org/10.1073/pnas.2010217118
Flacco, M. E., Manzoli, L., De Giorgio, R., Gasbarrini, A., Cicchetti, A., Bravi, F., Altini, M., Caio, G. P., & Ursini, F. (2019). Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis. Eur Rev Med Pharmacol Sci, 23(7), 2986-3000. https://doi.org/10.26355/eurrev_201904_17580
Forbes, J. D., Chen, C. Y., Knox, N. C., Marrie, R. A., El-Gabalawy, H., de Kievit, T., Alfa, M., Bernstein, C. N., & Van Domselaar, G. (2018). A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? Microbiome, 6(1), 221. https://doi.org/10.1186/s40168-018-0603-4
Ford, A. C., & Moayyedi, P. (2010). Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther, 32(2), 144-158. https://doi.org/10.1111/j.1365-2036.2010.04328.x
Ford, A. C., Moayyedi, P., Chey, W. D., Harris, L. A., Lacy, B. E., Saito, Y. A., Quigley, E. M. M., & Syndrome, A. C. G. T. F. o. M. o. I. B. (2018). American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. Am J Gastroenterol, 113(Suppl 2), 1-18. https://doi.org/10.1038/s41395-018-0084-x
Ford, A. C., Sperber, A. D., Corsetti, M., & Camilleri, M. (2020). Irritable bowel syndrome. Lancet, 396(10263), 1675-1688. https://doi.org/10.1016/S0140-6736(20)31548-8
Franc, A., Vetchy, D., & Fulopova, N. (2022). Commercially Available Enteric Empty Hard Capsules, Production Technology and Application. Pharmaceuticals (Basel), 15(11). https://doi.org/10.3390/ph15111398
Francis, C. Y., Morris, J., & Whorwell, P. J. (1997). The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther, 11(2), 395-402. https://doi.org/10.1046/j.1365-2036.1997.142318000.x
Frandemark, A., Tornblom, H., Jakobsson, S., & Simren, M. (2018). Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem. Am J Gastroenterol, 113(10), 1540-1549. https://doi.org/10.1038/s41395-018-0262-x
Franzosa, E. A., Morgan, X. C., Segata, N., Waldron, L., Reyes, J., Earl, A. M., Giannoukos, G., Boylan, M. R., Ciulla, D., Gevers, D., Izard, J., Garrett, W. S., Chan, A. T., & Huttenhower, C. (2014). Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci U S A, 111(22), E2329-2338. https://doi.org/10.1073/pnas.1319284111
Frost, G., Sleeth, M. L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L., Anastasovska, J., Ghourab, S., Hankir, M., Zhang, S., Carling, D., Swann, J. R., Gibson, G., Viardot, A., Morrison, D., Louise Thomas, E., & Bell, J. D. (2014). The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun, 5, 3611. https://doi.org/10.1038/ncomms4611
Fujimura, K. E., Demoor, T., Rauch, M., Faruqi, A. A., Jang, S., Johnson, C. C., Boushey, H. A., Zoratti, E., Ownby, D., Lukacs, N. W., & Lynch, S. V. (2014). House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc Natl Acad Sci U S A, 111(2), 805-810. https://doi.org/10.1073/pnas.1310750111
Galtier, M., De Sordi, L., Sivignon, A., de Vallee, A., Maura, D., Neut, C., Rahmouni, O., Wannerberger, K., Darfeuille-Michaud, A., Desreumaux, P., Barnich, N., & Debarbieux, L. (2017). Bacteriophages Targeting Adherent Invasive Escherichia coli Strains as a Promising New Treatment for Crohn's Disease. J Crohns Colitis, 11(7), 840-847. https://doi.org/10.1093/ecco-jcc/jjw224
Garcia-Gamboa, R., Kirchmayr, M. R., Gradilla-Hernandez, M. S., Perez-Brocal, V., Moya, A., & Gonzalez-Avila, M. (2021). The intestinal mycobiota and its relationship with overweight, obesity and nutritional aspects. J Hum Nutr Diet, 34(4), 645-655. https://doi.org/10.1111/jhn.12864
Gevers, D., Kugathasan, S., Denson, L. A., Vazquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., Morgan, X. C., Kostic, A. D., Luo, C., Gonzalez, A., McDonald, D., Haberman, Y., Walters, T., Baker, S., Rosh, J., . . . Xavier, R. J. (2014). The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe, 15(3), 382-392. https://doi.org/10.1016/j.chom.2014.02.005
Ghoshal, U., Shukla, R., Srivastava, D., & Ghoshal, U. C. (2016). Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in Methanobrevibacter smithii, Which Is Associated with Higher Methane Production. Gut Liver, 10(6), 932-938. https://doi.org/10.5009/gnl15588
Goll, R., Johnsen, P. H., Hjerde, E., Diab, J., Valle, P. C., Hilpusch, F., & Cavanagh, J. P. (2020). Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome. Gut Microbes, 12(1), 1794263. https://doi.org/10.1080/19490976.2020.1794263
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., Spector, T. D., Clark, A. G., & Ley, R. E. (2014). Human genetics shape the gut microbiome. Cell, 159(4), 789-799. https://doi.org/10.1016/j.cell.2014.09.053
Gosalbes, M. J., Llop, S., Valles, Y., Moya, A., Ballester, F., & Francino, M. P. (2013). Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants. Clin Exp Allergy, 43(2), 198-211. https://doi.org/10.1111/cea.12063
Guindo, C. O., Drancourt, M., & Grine, G. (2020). Digestive tract methanodrome: Physiological roles of human microbiota-associated methanogens. Microb Pathog, 149, 104425. https://doi.org/10.1016/j.micpath.2020.104425
Guo, Q., Lin, H., Chen, P., Tan, S., Wen, Z., Lin, L., He, J., Wen, J., & Lu, S. (2021). Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules. Bioengineered, 12(2), 11885-11897. https://doi.org/10.1080/21655979.2021.1999374
Hakansson, A., Andren Aronsson, C., Brundin, C., Oscarsson, E., Molin, G., & Agardh, D. (2019). Effects of Lactobacillus plantarum and Lactobacillus paracasei on the Peripheral Immune Response in Children with Celiac Disease Autoimmunity: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients, 11(8). https://doi.org/10.3390/nu11081925
Halkjaer, S. I., Christensen, A. H., Lo, B. Z. S., Browne, P. D., Gunther, S., Hansen, L. H., & Petersen, A. M. (2018). Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut, 67(12), 2107-2115. https://doi.org/10.1136/gutjnl-2018-316434
Halkjaer, S. I., Lo, B., Cold, F., Hojer Christensen, A., Holster, S., Konig, J., Brummer, R. J., Aroniadis, O. C., Lahtinen, P., Holvoet, T., Gluud, L. L., & Petersen, A. M. (2023). Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. World J Gastroenterol, 29(20), 3185-3202. https://doi.org/10.3748/wjg.v29.i20.3185
Hall, A. B., Yassour, M., Sauk, J., Garner, A., Jiang, X., Arthur, T., Lagoudas, G. K., Vatanen, T., Fornelos, N., Wilson, R., Bertha, M., Cohen, M., Garber, J., Khalili, H., Gevers, D., Ananthakrishnan, A. N., Kugathasan, S., Lander, E. S., Blainey, P., . . . Huttenhower, C. (2017). A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med, 9(1), 103. https://doi.org/10.1186/s13073-017-0490-5
Henke, M. T., Kenny, D. J., Cassilly, C. D., Vlamakis, H., Xavier, R. J., & Clardy, J. (2019). Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide. Proc Natl Acad Sci U S A, 116(26), 12672-12677. https://doi.org/10.1073/pnas.1904099116
Hollister, E. B., Riehle, K., Luna, R. A., Weidler, E. M., Rubio-Gonzales, M., Mistretta, T. A., Raza, S., Doddapaneni, H. V., Metcalf, G. A., Muzny, D. M., Gibbs, R. A., Petrosino, J. F., Shulman, R. J., & Versalovic, J. (2015). Structure and function of the healthy pre-adolescent pediatric gut microbiome. Microbiome, 3, 36. https://doi.org/10.1186/s40168-015-0101-x
Holster, S., Lindqvist, C. M., Repsilber, D., Salonen, A., de Vos, W. M., Konig, J., & Brummer, R. J. (2019). The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study. Clin Transl Gastroenterol, 10(4), e00034. https://doi.org/10.14309/ctg.0000000000000034
Holvoet, T., Joossens, M., Vazquez-Castellanos, J. F., Christiaens, E., Heyerick, L., Boelens, J., Verhasselt, B., van Vlierberghe, H., De Vos, M., Raes, J., & De Looze, D. (2021). Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial. Gastroenterology, 160(1), 145-157 e148. https://doi.org/10.1053/j.gastro.2020.07.013
Hoyhtya, M., Korpela, K., Saqib, S., Junkkari, S., Nissila, E., Nikkonen, A., Dikareva, E., Salonen, A., de Vos, W. M., & Kolho, K. L. (2022). Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor alpha Antagonist Infliximab in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis. https://doi.org/10.1093/ibd/izac182
Hsiao, A., Ahmed, A. M., Subramanian, S., Griffin, N. W., Drewry, L. L., Petri, W. A., Jr., Haque, R., Ahmed, T., & Gordon, J. I. (2014). Members of the human gut microbiota involved in recovery from Vibrio cholerae infection. Nature, 515(7527), 423-426. https://doi.org/10.1038/nature13738
Hugerth, L. W., Andreasson, A., Talley, N. J., Forsberg, A. M., Kjellstrom, L., Schmidt, P. T., Agreus, L., & Engstrand, L. (2020). No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population. Gut, 69(6), 1076-1084. https://doi.org/10.1136/gutjnl-2019-318717
Human Microbiome Project, C. (2012). Structure, function and diversity of the healthy human microbiome. Nature, 486(7402), 207-214. https://doi.org/10.1038/nature11234
Hurych, J., Vodolanova, L., Vejmelka, J., Drevinek, P., Kohout, P., Cinek, O., & Nohynkova, E. (2022). Freezing of faeces dramatically decreases the viability of Blastocystis sp. and Dientamoeba fragilis. Eur J Gastroenterol Hepatol, 34(2), 242-243. https://doi.org/10.1097/MEG.0000000000002327
Husby, S., Koletzko, S., Korponay-Szabo, I., Kurppa, K., Mearin, M. L., Ribes-Koninckx, C., Shamir, R., Troncone, R., Auricchio, R., Castillejo, G., Christensen, R., Dolinsek, J., Gillett, P., Hrobjartsson, A., Koltai, T., Maki, M., Nielsen, S. M., Popp, A., Stordal, K., . . . Wessels, M. (2020). European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr, 70(1), 141-156. https://doi.org/10.1097/MPG.0000000000002497
Chassard, C., Dapoigny, M., Scott, K. P., Crouzet, L., Del'homme, C., Marquet, P., Martin, J. C., Pickering, G., Ardid, D., Eschalier, A., Dubray, C., Flint, H. J., & Bernalier-Donadille, A. (2012). Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther, 35(7), 828-838. https://doi.org/10.1111/j.1365-2036.2012.05007.x
Cheng, J., Ringel-Kulka, T., Heikamp-de Jong, I., Ringel, Y., Carroll, I., de Vos, W. M., Salojarvi, J., & Satokari, R. (2016). Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children. ISME J, 10(4), 1002-1014. https://doi.org/10.1038/ismej.2015.177
Cho, I., Yamanishi, S., Cox, L., Methe, B. A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., Li, H., Alekseyenko, A. V., & Blaser, M. J. (2012). Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature, 488(7413), 621-626. https://doi.org/10.1038/nature11400
Illi, S., Depner, M., Genuneit, J., Horak, E., Loss, G., Strunz-Lehner, C., Buchele, G., Boznanski, A., Danielewicz, H., Cullinan, P., Heederik, D., Braun-Fahrlander, C., von Mutius, E., & Group, G. S. (2012). Protection from childhood asthma and allergy in Alpine farm environments-the GABRIEL Advanced Studies. J Allergy Clin Immunol, 129(6), 1470-1477 e1476. https://doi.org/10.1016/j.jaci.2012.03.013
Imai, T., Inoue, R., Kawada, Y., Morita, Y., Inatomi, O., Nishida, A., Bamba, S., Kawahara, M., & Andoh, A. (2019). Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease. J Gastroenterol, 54(2), 149-159. https://doi.org/10.1007/s00535-018-1530-7
Jenickova, E., Andren Aronsson, C., Mascellani Bergo, A., Cinek, O., Havlik, J., & Agardh, D. (2023). Effects of Lactiplantibacillus plantarum and Lacticaseibacillus paracasei supplementation on the faecal metabolome in children with coeliac disease autoimmunity: a randomised, double-blinded placebo-controlled clinical trial. Front Nutr, 10, 1183963. https://doi.org/10.3389/fnut.2023.1183963
Jirku, M., Kasparova, A., Lhotska, Z., Obornik, M., Brozova, K., Petrzelkova, K. J., Samas, P., Kadlecova, O., Stensvold, C. R., & Jirku, K. (2022). A Cross-Sectional Study on the Occurrence of the Intestinal Protist, Dientamoeba fragilis, in the Gut-Healthy Volunteers and Their Animals. Int J Mol Sci, 23(23). https://doi.org/10.3390/ijms232315407
Johnsen, P. H., Hilpusch, F., Cavanagh, J. P., Leikanger, I. S., Kolstad, C., Valle, P. C., & Goll, R. (2018). Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol, 3(1), 17-24. https://doi.org/10.1016/S2468-1253(17)30338-2
Johnson, C. C., Ownby, D. R., Alford, S. H., Havstad, S. L., Williams, L. K., Zoratti, E. M., Peterson, E. L., & Joseph, C. L. (2005). Antibiotic exposure in early infancy and risk for childhood atopy. J Allergy Clin Immunol, 115(6), 1218-1224. https://doi.org/10.1016/j.jaci.2005.04.020
Jokelainen, P., Hebbelstrup Jensen, B., Andreassen, B. U., Petersen, A. M., Roser, D., Krogfelt, K. A., Nielsen, H. V., & Stensvold, C. R. (2017). Dientamoeba fragilis, a Commensal in Children in Danish Day Care Centers. J Clin Microbiol, 55(6), 1707-1713. https://doi.org/10.1128/JCM.00037-17
Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011). Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut, 60(5), 631-637. https://doi.org/10.1136/gut.2010.223263
Kahrs, C. R., Chuda, K., Tapia, G., Stene, L. C., Marild, K., Rasmussen, T., Ronningen, K. S., Lundin, K. E. A., Kramna, L., Cinek, O., & Stordal, K. (2019). Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort. BMJ, 364, l231. https://doi.org/10.1136/bmj.l231
Kapoor, A., Shandilya, M., & Kundu, S. (2011). Structural insight of dopamine beta-hydroxylase, a drug target for complex traits, and functional significance of exonic single nucleotide polymorphisms. PLoS One, 6(10), e26509. https://doi.org/10.1371/journal.pone.0026509
Karczewski, J., Poniedzialek, B., Adamski, Z., & Rzymski, P. (2014). The effects of the microbiota on the host immune system. Autoimmunity, 47(8), 494-504. https://doi.org/10.3109/08916934.2014.938322
Keller, J. J., Ooijevaar, R. E., Hvas, C. L., Terveer, E. M., Lieberknecht, S. C., Hogenauer, C., Arkkila, P., Sokol, H., Gridnyev, O., Megraud, F., Kump, P. K., Nakov, R., Goldenberg, S. D., Satokari, R., Tkatch, S., Sanguinetti, M., Cammarota, G., Dorofeev, A., Gubska, O., . . . Vehreschild, M. (2021). A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United European Gastroenterol J, 9(2), 229-247. https://doi.org/10.1177/2050640620967898
Kelly, C. P. (2013). Fecal microbiota transplantation--an old therapy comes of age. N Engl J Med, 368(5), 474-475. https://doi.org/10.1056/NEJMe1214816
Kemppainen, K. M., Lynch, K. F., Liu, E., Lonnrot, M., Simell, V., Briese, T., Koletzko, S., Hagopian, W., Rewers, M., She, J. X., Simell, O., Toppari, J., Ziegler, A. G., Akolkar, B., Krischer, J. P., Lernmark, A., Hyoty, H., Triplett, E. W., Agardh, D., & Group, T. S. (2017). Factors That Increase Risk of Celiac Disease Autoimmunity After a Gastrointestinal Infection in Early Life. Clin Gastroenterol Hepatol, 15(5), 694-702 e695. https://doi.org/10.1016/j.cgh.2016.10.033
Kennedy, K. M., de Goffau, M. C., Perez-Munoz, M. E., Arrieta, M. C., Backhed, F., Bork, P., Braun, T., Bushman, F. D., Dore, J., de Vos, W. M., Earl, A. M., Eisen, J. A., Elovitz, M. A., Ganal-Vonarburg, S. C., Ganzle, M. G., Garrett, W. S., Hall, L. J., Hornef, M. W., Huttenhower, C., . . . Walter, J. (2023). Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. Nature, 613(7945), 639-649. https://doi.org/10.1038/s41586-022-05546-8
Kerckhoffs, A. P. M., Ben-Amor, K., Samsom, M., van der Rest, M. E., de Vogel, J., Knol, J., & Akkermans, L. M. A. (2011). Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome. J Med Microbiol, 60(Pt 2), 236-245. https://doi.org/10.1099/jmm.0.022848-0
Knight, R., Vrbanac, A., Taylor, B. C., Aksenov, A., Callewaert, C., Debelius, J., Gonzalez, A., Kosciolek, T., McCall, L. I., McDonald, D., Melnik, A. V., Morton, J. T., Navas, J., Quinn, R. A., Sanders, J. G., Swafford, A. D., Thompson, L. R., Tripathi, A., Xu, Z. Z., . . . Dorrestein, P. C. (2018). Best practices for analysing microbiomes. Nat Rev Microbiol, 16(7), 410-422. https://doi.org/10.1038/s41579-018-0029-9
Kolho, K. L., Korpela, K., Jaakkola, T., Pichai, M. V., Zoetendal, E. G., Salonen, A., & de Vos, W. M. (2015). Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation. Am J Gastroenterol, 110(6), 921-930. https://doi.org/10.1038/ajg.2015.149
Kondrashova, A., Mustalahti, K., Kaukinen, K., Viskari, H., Volodicheva, V., Haapala, A. M., Ilonen, J., Knip, M., Maki, M., Hyoty, H., & Epivir Study, G. (2008). Lower economic status and inferior hygienic environment may protect against celiac disease. Ann Med, 40(3), 223-231. https://doi.org/10.1080/07853890701678689
Konig, J., Siebenhaar, A., Hogenauer, C., Arkkila, P., Nieuwdorp, M., Noren, T., Ponsioen, C. Y., Rosien, U., Rossen, N. G., Satokari, R., Stallmach, A., de Vos, W., Keller, J., & Brummer, R. J. (2017). Consensus report: faecal microbiota transfer - clinical applications and procedures. Aliment Pharmacol Ther, 45(2), 222-239. https://doi.org/10.1111/apt.13868
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016). Bowel Disorders. Gastroenterology. https://doi.org/S0016-5085(16)00222-5 [pii]
10.1053/j.gastro.2016.02.031
Lahtinen, P., Jalanka, J., Hartikainen, A., Mattila, E., Hillila, M., Punkkinen, J., Koskenpato, J., Anttila, V. J., Tillonen, J., Satokari, R., & Arkkila, P. (2020). Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome. Aliment Pharmacol Ther, 51(12), 1321-1331. https://doi.org/10.1111/apt.15740
Lau, J. T., Whelan, F. J., Herath, I., Lee, C. H., Collins, S. M., Bercik, P., & Surette, M. G. (2016). Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling. Genome Med, 8(1), 72. https://doi.org/10.1186/s13073-016-0327-7
Le Bastard, Q., Al-Ghalith, G. A., Gregoire, M., Chapelet, G., Javaudin, F., Dailly, E., Batard, E., Knights, D., & Montassier, E. (2018). Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications. Aliment Pharmacol Ther, 47(3), 332-345. https://doi.org/10.1111/apt.14451
Lebwohl, B., & Rubio-Tapia, A. (2021). Epidemiology, Presentation, and Diagnosis of Celiac Disease. Gastroenterology, 160(1), 63-75. https://doi.org/10.1053/j.gastro.2020.06.098
Lederberg, J. M., A.T. . (2001). 'Ome Sweet 'Omics--A Genealogical Treasury of Words [Commentary]. The Scientist, 15(7). https://www.the-scientist.com/commentary/ome-sweet-omics---a-genealogical-treasury-of-words-54889
Lee, C. H., Steiner, T., Petrof, E. O., Smieja, M., Roscoe, D., Nematallah, A., Weese, J. S., Collins, S., Moayyedi, P., Crowther, M., Ropeleski, M. J., Jayaratne, P., Higgins, D., Li, Y., Rau, N. V., & Kim, P. T. (2016). Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. JAMA, 315(2), 142-149. https://doi.org/10.1001/jama.2015.18098
Leonard, M. M., Valitutti, F., Karathia, H., Pujolassos, M., Kenyon, V., Fanelli, B., Troisi, J., Subramanian, P., Camhi, S., Colucci, A., Serena, G., Cucchiara, S., Trovato, C. M., Malamisura, B., Francavilla, R., Elli, L., Hasan, N. A., Zomorrodi, A. R., Colwell, R., . . . Team, C.-G. (2021). Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study. Proc Natl Acad Sci U S A, 118(29). https://doi.org/10.1073/pnas.2020322118
Lepp, P. W., Brinig, M. M., Ouverney, C. C., Palm, K., Armitage, G. C., & Relman, D. A. (2004). Methanogenic Archaea and human periodontal disease. Proc Natl Acad Sci U S A, 101(16), 6176-6181. https://doi.org/10.1073/pnas.0308766101
Lewis, J. D., Chen, E. Z., Baldassano, R. N., Otley, A. R., Griffiths, A. M., Lee, D., Bittinger, K., Bailey, A., Friedman, E. S., Hoffmann, C., Albenberg, L., Sinha, R., Compher, C., Gilroy, E., Nessel, L., Grant, A., Chehoud, C., Li, H., Wu, G. D., & Bushman, F. D. (2015). Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease. Cell Host Microbe, 18(4), 489-500. https://doi.org/10.1016/j.chom.2015.09.008
Lhotska, Z., Jirku, M., Hlozkova, O., Brozova, K., Jirsova, D., Stensvold, C. R., Kolisko, M., & Jirku Pomajbikova, K. (2020). A Study on the Prevalence and Subtype Diversity of the Intestinal Protist Blastocystis sp. in a Gut-Healthy Human Population in the Czech Republic. Front Cell Infect Microbiol, 10, 544335. https://doi.org/10.3389/fcimb.2020.544335
Li, G., Yang, M., Jin, Y., Li, Y., Qian, W., Xiong, H., Song, J., & Hou, X. (2018). Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome. J Gastroenterol Hepatol, 33(6), 1220-1226. https://doi.org/10.1111/jgh.14059
Liang, G., & Bushman, F. D. (2021). The human virome: assembly, composition and host interactions. Nat Rev Microbiol, 19(8), 514-527. https://doi.org/10.1038/s41579-021-00536-5
Liu, C., Li, J., Zhang, Y., Philip, A., Shi, E., Chi, X., & Meng, J. (2015). Influence of glucose fermentation on CO(2) assimilation to acetate in homoacetogen Blautia coccoides GA-1. J Ind Microbiol Biotechnol, 42(9), 1217-1224. https://doi.org/10.1007/s10295-015-1646-1
Liu, E., Dong, F., Baron, A. E., Taki, I., Norris, J. M., Frohnert, B. I., Hoffenberg, E. J., & Rewers, M. (2017). High Incidence of Celiac Disease in a Long-term Study of Adolescents With Susceptibility Genotypes. Gastroenterology, 152(6), 1329-1336 e1321. https://doi.org/10.1053/j.gastro.2017.02.002
Liu, Y., Zhang, L., Wang, X., Wang, Z., Zhang, J., Jiang, R., Wang, X., Wang, K., Liu, Z., Xia, Z., Xu, Z., Nie, Y., Lv, X., Wu, X., Zhu, H., & Duan, L. (2016). Similar Fecal Microbiota Signatures in Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Patients With Depression. Clin Gastroenterol Hepatol, 14(11), 1602-1611 e1605. https://doi.org/10.1016/j.cgh.2016.05.033
Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., Casero, D., Courtney, H., Gonzalez, A., Graeber, T. G., Hall, A. B., Lake, K., Landers, C. J., Mallick, H., Plichta, D. R., . . . Huttenhower, C. (2019). Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature, 569(7758), 655-662. https://doi.org/10.1038/s41586-019-1237-9
Lopez-Siles, M., Duncan, S. H., Garcia-Gil, L. J., & Martinez-Medina, M. (2017). Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J, 11(4), 841-852. https://doi.org/10.1038/ismej.2016.176
Lynch, S. V., & Pedersen, O. (2016). The Human Intestinal Microbiome in Health and Disease. N Engl J Med, 375(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
Maccaferri, S., Candela, M., Turroni, S., Centanni, M., Severgnini, M., Consolandi, C., Cavina, P., & Brigidi, P. (2012). IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation. Gut Microbes, 3(5), 406-413. https://doi.org/10.4161/gmic.21009
Maloney, J. G., Molokin, A., da Cunha, M. J. R., Cury, M. C., & Santin, M. (2020). Blastocystis subtype distribution in domestic and captive wild bird species from Brazil using next generation amplicon sequencing. Parasite Epidemiol Control, 9, e00138. https://doi.org/10.1016/j.parepi.2020.e00138
S2405-6731(20)30007-6 [pii]
e00138 [pii]
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., Roca, J., & Dore, J. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut, 55(2), 205-211. https://doi.org/10.1136/gut.2005.073817
Marcobal, A., Kashyap, P. C., Nelson, T. A., Aronov, P. A., Donia, M. S., Spormann, A., Fischbach, M. A., & Sonnenburg, J. L. (2013). A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J, 7(10), 1933-1943. https://doi.org/10.1038/ismej.2013.89
Marchesi, J. R., Holmes, E., Khan, F., Kochhar, S., Scanlan, P., Shanahan, F., Wilson, I. D., & Wang, Y. (2007). Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res, 6(2), 546-551. https://doi.org/10.1021/pr060470d
Marchesi, J. R., & Ravel, J. (2015). The vocabulary of microbiome research: a proposal. Microbiome, 3, 31. https://doi.org/10.1186/s40168-015-0094-5
Marsh, A., Eslick, E. M., & Eslick, G. D. (2016). Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr, 55(3), 897-906. https://doi.org/10.1007/s00394-015-0922-1
Martens, E. C., Chiang, H. C., & Gordon, J. I. (2008). Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe, 4(5), 447-457. https://doi.org/10.1016/j.chom.2008.09.007
Maurice, C. F., Haiser, H. J., & Turnbaugh, P. J. (2013). Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell, 152(1-2), 39-50. https://doi.org/10.1016/j.cell.2012.10.052
Merino, V. R., Nakano, V., Liu, C., Song, Y., Finegold, S. M., & Avila-Campos, M. J. (2011). Quantitative detection of enterotoxigenic Bacteroides fragilis subtypes isolated from children with and without diarrhea. J Clin Microbiol, 49(1), 416-418. https://doi.org/10.1128/JCM.01556-10
Metwaly, A., Dunkel, A., Waldschmitt, N., Raj, A. C. D., Lagkouvardos, I., Corraliza, A. M., Mayorgas, A., Martinez-Medina, M., Reiter, S., Schloter, M., Hofmann, T., Allez, M., Panes, J., Salas, A., & Haller, D. (2020). Integrated microbiota and metabolite profiles link Crohn's disease to sulfur metabolism. Nat Commun, 11(1), 4322. https://doi.org/10.1038/s41467-020-17956-1
Mirjalali, H., Abbasi, M. R., Naderi, N., Hasani, Z., Mirsamadi, E. S., Stensvold, C. R., Balaii, H., Asadzadeh Aghdaei, H., & Zali, M. R. (2017). Distribution and phylogenetic analysis of Blastocystis sp. subtypes isolated from IBD patients and healthy individuals in Iran. Eur J Clin Microbiol Infect Dis, 36(12), 2335-2342. https://doi.org/10.1007/s10096-017-3065-x
Mohammad, N. A., Al-Mekhlafi, H. M., Moktar, N., & Anuar, T. S. (2017). Prevalence and risk factors of Blastocystis infection among underprivileged communities in rural Malaysia. Asian Pac J Trop Med, 10(5), 491-497. https://doi.org/10.1016/j.apjtm.2017.05.001
Moissl-Eichinger, C., Pausan, M., Taffner, J., Berg, G., Bang, C., & Schmitz, R. A. (2018). Archaea Are Interactive Components of Complex Microbiomes. Trends Microbiol, 26(1), 70-85. https://doi.org/10.1016/j.tim.2017.07.004
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., Bousvaros, A., Korzenik, J., Sands, B. E., Xavier, R. J., & Huttenhower, C. (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol, 13(9), R79. https://doi.org/10.1186/gb-2012-13-9-r79
Mukherjee, A., Lordan, C., Ross, R. P., & Cotter, P. D. (2020). Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. Gut Microbes, 12(1), 1802866. https://doi.org/10.1080/19490976.2020.1802866
Mukherjee, S., Seshadri, R., Varghese, N. J., Eloe-Fadrosh, E. A., Meier-Kolthoff, J. P., Goker, M., Coates, R. C., Hadjithomas, M., Pavlopoulos, G. A., Paez-Espino, D., Yoshikuni, Y., Visel, A., Whitman, W. B., Garrity, G. M., Eisen, J. A., Hugenholtz, P., Pati, A., Ivanova, N. N., Woyke, T., . . . Kyrpides, N. C. (2017). 1,003 reference genomes of bacterial and archaeal isolates expand coverage of the tree of life. Nat Biotechnol, 35(7), 676-683. https://doi.org/10.1038/nbt.3886
Murugesan, S., Nirmalkar, K., Hoyo-Vadillo, C., Garcia-Espitia, M., Ramirez-Sanchez, D., & Garcia-Mena, J. (2018). Gut microbiome production of short-chain fatty acids and obesity in children. Eur J Clin Microbiol Infect Dis, 37(4), 621-625. https://doi.org/10.1007/s10096-017-3143-0
Nash, A. K., Auchtung, T. A., Wong, M. C., Smith, D. P., Gesell, J. R., Ross, M. C., Stewart, C. J., Metcalf, G. A., Muzny, D. M., Gibbs, R. A., Ajami, N. J., & Petrosino, J. F. (2017). The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome, 5(1), 153. https://doi.org/10.1186/s40168-017-0373-4
Nayfach, S., Paez-Espino, D., Call, L., Low, S. J., Sberro, H., Ivanova, N. N., Proal, A. D., Fischbach, M. A., Bhatt, A. S., Hugenholtz, P., & Kyrpides, N. C. (2021). Metagenomic compendium of 189,680 DNA viruses from the human gut microbiome. Nat Microbiol, 6(7), 960-970. https://doi.org/10.1038/s41564-021-00928-6
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., Sung, J. J. Y., & Kaplan, G. G. (2017). Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 390(10114), 2769-2778. https://doi.org/10.1016/S0140-6736(17)32448-0
Nieves-Ramirez, M. E., Partida-Rodriguez, O., Laforest-Lapointe, I., Reynolds, L. A., Brown, E. M., Valdez-Salazar, A., Moran-Silva, P., Rojas-Velazquez, L., Morien, E., Parfrey, L. W., Jin, M., Walter, J., Torres, J., Arrieta, M. C., Ximenez-Garcia, C., & Finlay, B. B. (2018). Asymptomatic Intestinal Colonization with Protist Blastocystis Is Strongly Associated with Distinct Microbiome Ecological Patterns. mSystems, 3(3). https://doi.org/10.1128/mSystems.00007-18
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012). Host-gut microbiota metabolic interactions. Science, 336(6086), 1262-1267. https://doi.org/10.1126/science.1223813
Norman, J. M., Handley, S. A., Baldridge, M. T., Droit, L., Liu, C. Y., Keller, B. C., Kambal, A., Monaco, C. L., Zhao, G., Fleshner, P., Stappenbeck, T. S., McGovern, D. P., Keshavarzian, A., Mutlu, E. A., Sauk, J., Gevers, D., Xavier, R. J., Wang, D., Parkes, M., & Virgin, H. W. (2015). Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell, 160(3), 447-460. https://doi.org/10.1016/j.cell.2015.01.002
Ogren, J., Dienus, O., Lofgren, S., Einemo, I. M., Iveroth, P., & Matussek, A. (2015). Dientamoeba fragilis prevalence coincides with gastrointestinal symptoms in children less than 11 years old in Sweden. Eur J Clin Microbiol Infect Dis, 34(10), 1995-1998. https://doi.org/10.1007/s10096-015-2442-6
Ogren, J., Van Nguyen, S., Nguyen, M. K., Dimberg, J., & Matussek, A. (2016). Prevalence of Dientamoeba fragilis, Giardia duodenalis, Entamoeba histolytica/dispar, and Cryptosporidium spp in Da Nang, Vietnam, detected by a multiplex real-time PCR. APMIS, 124(6), 529-533. https://doi.org/10.1111/apm.12535
Oikarinen, M., Puustinen, L., Lehtonen, J., Hakola, L., Simell, S., Toppari, J., Ilonen, J., Veijola, R., Virtanen, S. M., Knip, M., & Hyoty, H. (2020). Enterovirus Infections Are Associated With the Development of Celiac Disease in a Birth Cohort Study. Front Immunol, 11, 604529. https://doi.org/10.3389/fimmu.2020.604529
Olivares, M., Neef, A., Castillejo, G., Palma, G. D., Varea, V., Capilla, A., Palau, F., Nova, E., Marcos, A., Polanco, I., Ribes-Koninckx, C., Ortigosa, L., Izquierdo, L., & Sanz, Y. (2015). The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut, 64(3), 406-417. https://doi.org/10.1136/gutjnl-2014-306931
Oliveira-Arbex, A. P., David, E. B., Caccio, S. M., Fonseca, C., Martin, J. G., Kurokawa, C. S., Tosini, F., Souza Neto, J. A., & Guimaraes, S. (2021). Prevalence and genetic characterization of Dientamoeba fragilis in asymptomatic children attending daycare centers. Rev Inst Med Trop Sao Paulo, 63, e39. https://doi.org/10.1590/S1678-9946202163039
Oliveira-Arbex, A. P., David, E. B., & Guimaraes, S. (2018). Blastocystis genetic diversity among children of low-income daycare center in Southeastern Brazil. Infect Genet Evol, 57, 59-63. https://doi.org/10.1016/j.meegid.2017.11.005
Ong, D. K., Mitchell, S. B., Barrett, J. S., Shepherd, S. J., Irving, P. M., Biesiekierski, J. R., Smith, S., Gibson, P. R., & Muir, J. G. (2010). Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol, 25(8), 1366-1373. https://doi.org/10.1111/j.1440-1746.2010.06370.x
Oscarsson, E., Hakansson, A., Andren Aronsson, C., Molin, G., & Agardh, D. (2021). Effects of Probiotic Bacteria Lactobacillaceae on the Gut Microbiota in Children With Celiac Disease Autoimmunity: A Placebo-Controlled and Randomized Clinical Trial. Front Nutr, 8, 680771. https://doi.org/10.3389/fnut.2021.680771
Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Folsch, U. R., Timmis, K. N., & Schreiber, S. (2004). Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut, 53(5), 685-693. https://doi.org/10.1136/gut.2003.025403
Ott, S. J., Waetzig, G. H., Rehman, A., Moltzau-Anderson, J., Bharti, R., Grasis, J. A., Cassidy, L., Tholey, A., Fickenscher, H., Seegert, D., Rosenstiel, P., & Schreiber, S. (2017). Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection. Gastroenterology, 152(4), 799-811 e797. https://doi.org/10.1053/j.gastro.2016.11.010
Palmela, C., Chevarin, C., Xu, Z., Torres, J., Sevrin, G., Hirten, R., Barnich, N., Ng, S. C., & Colombel, J. F. (2018). Adherent-invasive Escherichia coli in inflammatory bowel disease. Gut, 67(3), 574-587. https://doi.org/10.1136/gutjnl-2017-314903
Parker, B. J., Wearsch, P. A., Veloo, A. C. M., & Rodriguez-Palacios, A. (2020). The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health. Front Immunol, 11, 906. https://doi.org/10.3389/fimmu.2020.00906
Pascal, V., Pozuelo, M., Borruel, N., Casellas, F., Campos, D., Santiago, A., Martinez, X., Varela, E., Sarrabayrouse, G., Machiels, K., Vermeire, S., Sokol, H., Guarner, F., & Manichanh, C. (2017). A microbial signature for Crohn's disease. Gut, 66(5), 813-822. https://doi.org/10.1136/gutjnl-2016-313235
Patel, S. M., Stason, W. B., Legedza, A., Ock, S. M., Kaptchuk, T. J., Conboy, L., Canenguez, K., Park, J. K., Kelly, E., Jacobson, E., Kerr, C. E., & Lembo, A. J. (2005). The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil, 17(3), 332-340. https://doi.org/10.1111/j.1365-2982.2005.00650.x
Peleg, A. Y., Hogan, D. A., & Mylonakis, E. (2010). Medically important bacterial-fungal interactions. Nat Rev Microbiol, 8(5), 340-349. https://doi.org/10.1038/nrmicro2313
Perez-Brocal, V., Garcia-Lopez, R., Vazquez-Castellanos, J. F., Nos, P., Beltran, B., Latorre, A., & Moya, A. (2013). Study of the viral and microbial communities associated with Crohn's disease: a metagenomic approach. Clin Transl Gastroenterol, 4(6), e36. https://doi.org/10.1038/ctg.2013.9
Petersen, A. M., Stensvold, C. R., Mirsepasi, H., Engberg, J., Friis-Moller, A., Porsbo, L. J., Hammerum, A. M., Nordgaard-Lassen, I., Nielsen, H. V., & Krogfelt, K. A. (2013). Active ulcerative colitis associated with low prevalence of Blastocystis and Dientamoeba fragilis infection. Scand J Gastroenterol, 48(5), 638-639. https://doi.org/10.3109/00365521.2013.780094
Pichler, J., Ong, C., Shah, N., Sebire, N., Kiparrissi, F., Borrelli, O., Pilkington, C., & Elawad, M. (2016). Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis. Pediatr Res, 79(6), 895-901. https://doi.org/10.1038/pr.2016.27
Pinto-Sanchez, M. I., Hall, G. B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J. T., Martin, F. P., Cominetti, O., Welsh, C., Rieder, A., Traynor, J., Gregory, C., De Palma, G., Pigrau, M., Ford, A. C., Macri, J., Berger, B., Bergonzelli, G., Surette, M. G., . . . Bercik, P. (2017). Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology, 153(2), 448-459 e448. https://doi.org/10.1053/j.gastro.2017.05.003
Pittayanon, R., Lau, J. T., Leontiadis, G. I., Tse, F., Yuan, Y., Surette, M., & Moayyedi, P. (2020). Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review. Gastroenterology, 158(4), 930-946 e931. https://doi.org/10.1053/j.gastro.2019.11.294
Pittayanon, R., Lau, J. T., Yuan, Y., Leontiadis, G. I., Tse, F., Surette, M., & Moayyedi, P. (2019). Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review. Gastroenterology, 157(1), 97-108. https://doi.org/10.1053/j.gastro.2019.03.049
Poulsen, C. S., Efunshile, A. M., Nelson, J. A., & Stensvold, C. R. (2016). Epidemiological Aspects of Blastocystis Colonization in Children in Ilero, Nigeria. Am J Trop Med Hyg, 95(1), 175-179. https://doi.org/10.4269/ajtmh.16-0074
Pozuelo, M., Panda, S., Santiago, A., Mendez, S., Accarino, A., Santos, J., Guarner, F., Azpiroz, F., & Manichanh, C. (2015). Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci Rep, 5, 12693. https://doi.org/10.1038/srep12693
Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., Mende, D. R., Li, J., Xu, J., Li, S., Li, D., Cao, J., Wang, B., Liang, H., Zheng, H., . . . Wang, J. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464(7285), 59-65. https://doi.org/10.1038/nature08821
Rajilic-Stojanovic, M., Biagi, E., Heilig, H. G., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011). Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology, 141(5), 1792-1801. https://doi.org/10.1053/j.gastro.2011.07.043
Ramakrishna, B. S. (2013). Role of the gut microbiota in human nutrition and metabolism. J Gastroenterol Hepatol, 28 Suppl 4, 9-17. https://doi.org/10.1111/jgh.12294
Rangel, I., Sundin, J., Fuentes, S., Repsilber, D., de Vos, W. M., & Brummer, R. J. (2015). The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects. Aliment Pharmacol Ther, 42(10), 1211-1221. https://doi.org/10.1111/apt.13399
Rasmussen, T. S., Mentzel, C. M. J., Kot, W., Castro-Mejia, J. L., Zuffa, S., Swann, J. R., Hansen, L. H., Vogensen, F. K., Hansen, A. K., & Nielsen, D. S. (2020). Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model. Gut, 69(12), 2122-2130. https://doi.org/10.1136/gutjnl-2019-320005
Rigsbee, L., Agans, R., Shankar, V., Kenche, H., Khamis, H. J., Michail, S., & Paliy, O. (2012). Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol, 107(11), 1740-1751. https://doi.org/10.1038/ajg.2012.287
Ringel-Kulka, T., Benson, A. K., Carroll, I. M., Kim, J., Legge, R. M., & Ringel, Y. (2016). Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating. Am J Physiol Gastrointest Liver Physiol, 310(6), G417-426. https://doi.org/10.1152/ajpgi.00044.2015
Riviere, A., Selak, M., Lantin, D., Leroy, F., & De Vuyst, L. (2016). Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut. Front Microbiol, 7, 979. https://doi.org/10.3389/fmicb.2016.00979
Roberts, T., Barratt, J., Harkness, J., Ellis, J., & Stark, D. (2011). Comparison of microscopy, culture, and conventional polymerase chain reaction for detection of blastocystis sp. in clinical stool samples. Am J Trop Med Hyg, 84(2), 308-312. https://doi.org/10.4269/ajtmh.2011.10-0447
Roda, G., Chien Ng, S., Kotze, P. G., Argollo, M., Panaccione, R., Spinelli, A., Kaser, A., Peyrin-Biroulet, L., & Danese, S. (2020). Crohn's disease. Nat Rev Dis Primers, 6(1), 22. https://doi.org/10.1038/s41572-020-0156-2
Rodrigues, V. F., Elias-Oliveira, J., Pereira, I. S., Pereira, J. A., Barbosa, S. C., Machado, M. S. G., & Carlos, D. (2022). Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes. Front Immunol, 13, 934695. https://doi.org/10.3389/fimmu.2022.934695
Rodriguez-Palacios, A., Conger, M., Hopperton A., Ezeji Jessica C.,, & Erkkila, H. L., Fiocchi C., Cominelli, F. (2019). Iidentification of pathogenic bacteria in severe Crohn’s disease. Gastroenterology, 156. https://doi.org/https://doi.org/10.1053/j.gastro.2019.01.238
Rook, G., Backhed, F., Levin, B. R., McFall-Ngai, M. J., & McLean, A. R. (2017). Evolution, human-microbe interactions, and life history plasticity. Lancet, 390(10093), 521-530. https://doi.org/10.1016/S0140-6736(17)30566-4
Roser, D., Simonsen, J., Nielsen, H. V., Stensvold, C. R., & Molbak, K. (2013). Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR. Eur J Clin Microbiol Infect Dis, 32(10), 1303-1310. https://doi.org/10.1007/s10096-013-1880-2
Rostami, A., Riahi, S. M., Haghighi, A., Saber, V., Armon, B., & Seyyedtabaei, S. J. (2017). The role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis. Parasitol Res, 116(9), 2361-2371. https://doi.org/10.1007/s00436-017-5535-6
10.1007/s00436-017-5535-6 [pii]
Roswall, J., Olsson, L. M., Kovatcheva-Datchary, P., Nilsson, S., Tremaroli, V., Simon, M. C., Kiilerich, P., Akrami, R., Kramer, M., Uhlen, M., Gummesson, A., Kristiansen, K., Dahlgren, J., & Backhed, F. (2021). Developmental trajectory of the healthy human gut microbiota during the first 5 years of life. Cell Host Microbe, 29(5), 765-776 e763. https://doi.org/10.1016/j.chom.2021.02.021
Russell, J. T., Roesch, L. F. W., Ordberg, M., Ilonen, J., Atkinson, M. A., Schatz, D. A., Triplett, E. W., & Ludvigsson, J. (2019). Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome. Nat Commun, 10(1), 3621. https://doi.org/10.1038/s41467-019-11460-x
Russell, W. R., Hoyles, L., Flint, H. J., & Dumas, M. E. (2013). Colonic bacterial metabolites and human health. Curr Opin Microbiol, 16(3), 246-254. https://doi.org/10.1016/j.mib.2013.07.002
Sanchez, E., Donat, E., Ribes-Koninckx, C., Fernandez-Murga, M. L., & Sanz, Y. (2013). Duodenal-mucosal bacteria associated with celiac disease in children. Appl Environ Microbiol, 79(18), 5472-5479. https://doi.org/10.1128/AEM.00869-13
Sassone-Corsi, M., & Raffatellu, M. (2015). No vacancy: how beneficial microbes cooperate with immunity to provide colonization resistance to pathogens. J Immunol, 194(9), 4081-4087. https://doi.org/10.4049/jimmunol.1403169
Scanlan, P. D., Knight, R., Song, S. J., Ackermann, G., & Cotter, P. D. (2016). Prevalence and genetic diversity of Blastocystis in family units living in the United States. Infect Genet Evol, 45, 95-97. https://doi.org/10.1016/j.meegid.2016.08.018
Scanlan, P. D., Stensvold, C. R., Rajilic-Stojanovic, M., Heilig, H. G., De Vos, W. M., O'Toole, P. W., & Cotter, P. D. (2014). The microbial eukaryote Blastocystis is a prevalent and diverse member of the healthy human gut microbiota. FEMS Microbiol Ecol, 90(1), 326-330. https://doi.org/10.1111/1574-6941.12396
Scudellari, M. (2017). News Feature: Cleaning up the hygiene hypothesis. Proc Natl Acad Sci U S A, 114(7), 1433-1436. https://doi.org/10.1073/pnas.1700688114
Selmer, T., & Andrei, P. I. (2001). p-Hydroxyphenylacetate decarboxylase from Clostridium difficile. A novel glycyl radical enzyme catalysing the formation of p-cresol. Eur J Biochem, 268(5), 1363-1372. https://doi.org/10.1046/j.1432-1327.2001.02001.x
Sender, R., Fuchs, S., & Milo, R. (2016). Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol, 14(8), e1002533. https://doi.org/10.1371/journal.pbio.1002533
Sessitsch, A., Wakelin, S., Schloter, M., Maguin, E., Cernava, T., Champomier-Verges, M. C., Charles, T. C., Cotter, P. D., Ferrocino, I., Kriaa, A., Lebre, P., Cowan, D., Lange, L., Kiran, S., Markiewicz, L., Meisner, A., Olivares, M., Sarand, I., Schelkle, B., . . . Kostic, T. (2023). Microbiome Interconnectedness throughout Environments with Major Consequences for Healthy People and a Healthy Planet. Microbiol Mol Biol Rev, 87(3), e0021222. https://doi.org/10.1128/mmbr.00212-22
Shkoporov, A. N., & Hill, C. (2019). Bacteriophages of the Human Gut: The "Known Unknown" of the Microbiome. Cell Host Microbe, 25(2), 195-209. https://doi.org/10.1016/j.chom.2019.01.017
Shukla, R., Ghoshal, U., Dhole, T. N., & Ghoshal, U. C. (2015). Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis. Dig Dis Sci, 60(10), 2953-2962. https://doi.org/10.1007/s10620-015-3607-y
Scholz, M., Ward, D. V., Pasolli, E., Tolio, T., Zolfo, M., Asnicar, F., Truong, D. T., Tett, A., Morrow, A. L., & Segata, N. (2016). Strain-level microbial epidemiology and population genomics from shotgun metagenomics. Nat Methods, 13(5), 435-438. https://doi.org/10.1038/nmeth.3802
Singh, P., Alm, E. J., Kelley, J. M., Cheng, V., Smith, M., Kassam, Z., Nee, J., Iturrino, J., & Lembo, A. (2022). Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D. Gut Microbes, 14(1), 2020067. https://doi.org/10.1080/19490976.2021.2020067
Singh, P., Arora, A., Strand, T. A., Leffler, D. A., Catassi, C., Green, P. H., Kelly, C. P., Ahuja, V., & Makharia, G. K. (2018). Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol, 16(6), 823-836 e822. https://doi.org/10.1016/j.cgh.2017.06.037
Singh, S., Murad, M. H., Fumery, M., Sedano, R., Jairath, V., Panaccione, R., Sandborn, W. J., & Ma, C. (2021). Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol, 6(12), 1002-1014. https://doi.org/10.1016/S2468-1253(21)00312-5
Sokol, H., Landman, C., Seksik, P., Berard, L., Montil, M., Nion-Larmurier, I., Bourrier, A., Le Gall, G., Lalande, V., De Rougemont, A., Kirchgesner, J., Daguenel, A., Cachanado, M., Rousseau, A., Drouet, E., Rosenzwajg, M., Hagege, H., Dray, X., Klatzman, D., . . . Simon, T. (2020). Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study. Microbiome, 8(1), 12. https://doi.org/10.1186/s40168-020-0792-5
Sokol, H., Leducq, V., Aschard, H., Pham, H. P., Jegou, S., Landman, C., Cohen, D., Liguori, G., Bourrier, A., Nion-Larmurier, I., Cosnes, J., Seksik, P., Langella, P., Skurnik, D., Richard, M. L., & Beaugerie, L. (2017). Fungal microbiota dysbiosis in IBD. Gut, 66(6), 1039-1048. https://doi.org/10.1136/gutjnl-2015-310746
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L. G., Gratadoux, J. J., Blugeon, S., Bridonneau, C., Furet, J. P., Corthier, G., Grangette, C., Vasquez, N., Pochart, P., Trugnan, G., Thomas, G., Blottiere, H. M., Dore, J., Marteau, P., Seksik, P., & Langella, P. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A, 105(43), 16731-16736. https://doi.org/10.1073/pnas.0804812105
Soleimani Jevinani, S., Mohammad Rahimi, H., Asri, N., Rostami-Nejad, M., Ahmadipour, S., & Mirjalali, H. (2023). Molecular epidemiology and subtyping of Blastocystis sp. and its subtypes in celiac patients; a case control study. Microb Pathog, 179, 106086. https://doi.org/10.1016/j.micpath.2023.106086
Sollid, L. M., Markussen, G., Ek, J., Gjerde, H., Vartdal, F., & Thorsby, E. (1989). Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med, 169(1), 345-350. https://doi.org/10.1084/jem.169.1.345
Sonnenburg, J. L., & Sonnenburg, E. D. (2019). Vulnerability of the industrialized microbiota. Science, 366(6464). https://doi.org/10.1126/science.aaw9255
Sperber, A. D., Dumitrascu, D., Fukudo, S., Gerson, C., Ghoshal, U. C., Gwee, K. A., Hungin, A. P. S., Kang, J. Y., Minhu, C., Schmulson, M., Bolotin, A., Friger, M., Freud, T., & Whitehead, W. (2017). The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut, 66(6), 1075-1082. https://doi.org/10.1136/gutjnl-2015-311240
Stark, D., Barratt, J., Chan, D., & Ellis, J. T. (2016). Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel. Clin Microbiol Rev, 29(3), 553-580. https://doi.org/10.1128/CMR.00076-15
Stastna, M., Norek, A., Radkova, J., Slukova, M., Hrunka, M., Jabandziev, P., & Janda, L. (2023). Increasing prevalence of celiac disease - where to look for answers? Epidemiol Mikrobiol Imunol, 72(3), 172-183. https://www.ncbi.nlm.nih.gov/pubmed/37871991 (Narust prevalence celiakie - kde hledat odpovedi?)
Stensvold, C. R., Arendrup, M. C., Jespersgaard, C., Molbak, K., & Nielsen, H. V. (2007). Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study. Diagn Microbiol Infect Dis, 59(3), 303-307. https://doi.org/10.1016/j.diagmicrobio.2007.06.003
Stensvold, C. R., Arendrup, M. C., Molbak, K., & Nielsen, H. V. (2007). The prevalence of Dientamoeba fragilis in patients with suspected enteroparasitic disease in a metropolitan area in Denmark. Clin Microbiol Infect, 13(8), 839-842. https://doi.org/10.1111/j.1469-0691.2007.01760.x
Stensvold, C. R., & Clark, C. G. (2016). Current status of Blastocystis: A personal view. Parasitol Int, 65(6 Pt B), 763-771. https://doi.org/10.1016/j.parint.2016.05.015
Stensvold, C. R., & Clark, C. G. (2020). Pre-empting Pandora's Box: Blastocystis Subtypes Revisited. Trends Parasitol, 36(3), 229-232. https://doi.org/10.1016/j.pt.2019.12.009
Stensvold, C. R., & van der Giezen, M. (2018). Associations between Gut Microbiota and Common Luminal Intestinal Parasites. Trends Parasitol, 34(5), 369-377. https://doi.org/10.1016/j.pt.2018.02.004
Stiemsma, L. T., Reynolds, L. A., Turvey, S. E., & Finlay, B. B. (2015). The hygiene hypothesis: current perspectives and future therapies. Immunotargets Ther, 4, 143-157. https://doi.org/10.2147/ITT.S61528
Stojek, M., Jablonska, A., & Adrych, K. (2021). The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease. J Clin Med, 10(18). https://doi.org/10.3390/jcm10184055
Strachan, D. P. (1989). Hay fever, hygiene, and household size. BMJ, 299(6710), 1259-1260. https://doi.org/10.1136/bmj.299.6710.1259
Tamboli, C. P., Neut, C., Desreumaux, P., & Colombel, J. F. (2004). Dysbiosis in inflammatory bowel disease. Gut, 53(1), 1-4. https://doi.org/10.1136/gut.53.1.1
Tana, C., Umesaki, Y., Imaoka, A., Handa, T., Kanazawa, M., & Fukudo, S. (2010). Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil, 22(5), 512-519, e114-515. https://doi.org/10.1111/j.1365-2982.2009.01427.x
Tap, J., Derrien, M., Tornblom, H., Brazeilles, R., Cools-Portier, S., Dore, J., Storsrud, S., Le Neve, B., Ohman, L., & Simren, M. (2017). Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. Gastroenterology, 152(1), 111-123 e118. https://doi.org/10.1053/j.gastro.2016.09.049
Tapia, G., Chuda, K., Kahrs, C. R., Stene, L. C., Kramna, L., Marild, K., Rasmussen, T., Ronningen, K. S., Cinek, O., & Stordal, K. (2021). Parechovirus Infection in Early Childhood and Association With Subsequent Celiac Disease. Am J Gastroenterol, 116(4), 788-795. https://doi.org/10.14309/ajg.0000000000001003
Terveer, E. M., van Gool, T., Ooijevaar, R. E., Sanders, I., Boeije-Koppenol, E., Keller, J. J., Bart, A., Kuijper, E. J., & Netherlands Donor Feces Bank Study, G. (2020). Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients. Clin Infect Dis, 71(10), 2630-2636. https://doi.org/10.1093/cid/ciz1122
Thaiss, C. A., Zeevi, D., Levy, M., Zilberman-Schapira, G., Suez, J., Tengeler, A. C., Abramson, L., Katz, M. N., Korem, T., Zmora, N., Kuperman, Y., Biton, I., Gilad, S., Harmelin, A., Shapiro, H., Halpern, Z., Segal, E., & Elinav, E. (2014). Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell, 159(3), 514-529. https://doi.org/10.1016/j.cell.2014.09.048
Tito, R. Y., Chaffron, S., Caenepeel, C., Lima-Mendez, G., Wang, J., Vieira-Silva, S., Falony, G., Hildebrand, F., Darzi, Y., Rymenans, L., Verspecht, C., Bork, P., Vermeire, S., Joossens, M., & Raes, J. (2019). Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiota. Gut, 68(7), 1180-1189. https://doi.org/10.1136/gutjnl-2018-316106
Torres, J., Mehandru, S., Colombel, J. F., & Peyrin-Biroulet, L. (2017). Crohn's disease. Lancet, 389(10080), 1741-1755. https://doi.org/10.1016/S0140-6736(16)31711-1
Turjeman, S., Sharon, E., Levin, R., Oralewska, B., Szaflarska-Poplawska, A., Bierla, J. B., Cukrowska, B., & Koren, O. (2023). Celiac-the lone horse? An autoimmune condition without signals of microbiota dysbiosis. Microbiol Spectr, e0146323. https://doi.org/10.1128/spectrum.01463-23
Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., & Gordon, J. I. (2007). The human microbiome project. Nature, 449(7164), 804-810. https://doi.org/10.1038/nature06244
van Rheenen, P. F., Aloi, M., Assa, A., Bronsky, J., Escher, J. C., Fagerberg, U. L., Gasparetto, M., Gerasimidis, K., Griffiths, A., Henderson, P., Koletzko, S., Kolho, K. L., Levine, A., van Limbergen, J., Martin de Carpi, F. J., Navas-Lopez, V. M., Oliva, S., de Ridder, L., Russell, R. K., . . . Ruemmele, F. M. (2020). The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update. J Crohns Colitis. https://doi.org/10.1093/ecco-jcc/jjaa161
Ventin-Holmberg, R., Eberl, A., Saqib, S., Korpela, K., Virtanen, S., Sipponen, T., Salonen, A., Saavalainen, P., & Nissila, E. (2021). Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease. J Crohns Colitis, 15(6), 1019-1031. https://doi.org/10.1093/ecco-jcc/jjaa252
Ventin-Holmberg, R., Hoyhtya, M., Saqib, S., Korpela, K., Nikkonen, A., Salonen, A., de Vos, W. M., & Kolho, K. L. (2022). The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-alpha. Sci Rep, 12(1), 6654. https://doi.org/10.1038/s41598-022-10548-7
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2006). Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut, 55(3), 426-431. https://doi.org/10.1136/gut.2005.069476
Vester-Andersen, M. K., Mirsepasi-Lauridsen, H. C., Prosberg, M. V., Mortensen, C. O., Trager, C., Skovsen, K., Thorkilgaard, T., Nojgaard, C., Vind, I., Krogfelt, K. A., Sorensen, N., Bendtsen, F., & Petersen, A. M. (2019). Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis. Sci Rep, 9(1), 13473. https://doi.org/10.1038/s41598-019-49833-3
Vich Vila, A., Imhann, F., Collij, V., Jankipersadsing, S. A., Gurry, T., Mujagic, Z., Kurilshikov, A., Bonder, M. J., Jiang, X., Tigchelaar, E. F., Dekens, J., Peters, V., Voskuil, M. D., Visschedijk, M. C., van Dullemen, H. M., Keszthelyi, D., Swertz, M. A., Franke, L., Alberts, R., . . . Weersma, R. K. (2018). Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med, 10(472). https://doi.org/10.1126/scitranslmed.aap8914
Walker, A. W., Martin, J. C., Scott, P., Parkhill, J., Flint, H. J., & Scott, K. P. (2015). 16S rRNA gene-based profiling of the human infant gut microbiota is strongly influenced by sample processing and PCR primer choice. Microbiome, 3, 26. https://doi.org/10.1186/s40168-015-0087-4
Walters, W. A., Caporaso, J. G., Lauber, C. L., Berg-Lyons, D., Fierer, N., & Knight, R. (2011). PrimerProspector: de novo design and taxonomic analysis of barcoded polymerase chain reaction primers. Bioinformatics, 27(8), 1159-1161. https://doi.org/10.1093/bioinformatics/btr087
Wang, S., Charbonnier, L. M., Noval Rivas, M., Georgiev, P., Li, N., Gerber, G., Bry, L., & Chatila, T. A. (2015). MyD88 Adaptor-Dependent Microbial Sensing by Regulatory T Cells Promotes Mucosal Tolerance and Enforces Commensalism. Immunity, 43(2), 289-303. https://doi.org/10.1016/j.immuni.2015.06.014
Wang, Y., Gao, X., Ghozlane, A., Hu, H., Li, X., Xiao, Y., Li, D., Yu, G., & Zhang, T. (2018). Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy. J Crohns Colitis, 12(3), 337-346. https://doi.org/10.1093/ecco-jcc/jjx153
Wang, Y., Gao, X., Zhang, X., Xiao, F., Hu, H., Li, X., Dong, F., Sun, M., Xiao, Y., Ge, T., Li, D., Yu, G., Liu, Z., & Zhang, T. (2021). Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease. Gut Microbes, 13(1), 1-18. https://doi.org/10.1080/19490976.2020.1865708
Wawrzyniak, I., Poirier, P., Viscogliosi, E., Dionigia, M., Texier, C., Delbac, F., & Alaoui, H. E. (2013). Blastocystis, an unrecognized parasite: an overview of pathogenesis and diagnosis. Ther Adv Infect Dis, 1(5), 167-178. https://doi.org/10.1177/2049936113504754
Weiss, G. A., & Hennet, T. (2017). Mechanisms and consequences of intestinal dysbiosis. Cell Mol Life Sci, 74(16), 2959-2977. https://doi.org/10.1007/s00018-017-2509-x
Wensel, C. R., Pluznick, J. L., Salzberg, S. L., & Sears, C. L. (2022). Next-generation sequencing: insights to advance clinical investigations of the microbiome. J Clin Invest, 132(7). https://doi.org/10.1172/JCI154944
Whipps, J. L., K.; Cooke, R;. (1988). Mycoparasitism and plant disease control. Manchester University Press.
Windey, K., De Preter, V., & Verbeke, K. (2012). Relevance of protein fermentation to gut health. Mol Nutr Food Res, 56(1), 184-196. https://doi.org/10.1002/mnfr.201100542
Windsor, J. J., & Johnson, E. H. (1999). Dientamoeba fragilis: the unflagellated human flagellate. Br J Biomed Sci, 56(4), 293-306. https://www.ncbi.nlm.nih.gov/pubmed/10795375
Wortelboer, K., Nieuwdorp, M., & Herrema, H. (2019). Fecal microbiota transplantation beyond Clostridioides difficile infections. EBioMedicine, 44, 716-729. https://doi.org/10.1016/j.ebiom.2019.05.066
Wright, E. K., Kamm, M. A., Teo, S. M., Inouye, M., Wagner, J., & Kirkwood, C. D. (2015). Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic review. Inflamm Bowel Dis, 21(6), 1219-1228. https://doi.org/10.1097/MIB.0000000000000382
Yallapragada, S. G., Nash, C. B., & Robinson, D. T. (2015). Early-Life Exposure to Antibiotics, Alterations in the Intestinal Microbiome, and Risk of Metabolic Disease in Children and Adults. Pediatr Ann, 44(11), e265-269. https://doi.org/10.3928/00904481-20151112-09
Yarza, P., Yilmaz, P., Pruesse, E., Glockner, F. O., Ludwig, W., Schleifer, K. H., Whitman, W. B., Euzeby, J., Amann, R., & Rossello-Mora, R. (2014). Uniting the classification of cultured and uncultured bacteria and archaea using 16S rRNA gene sequences. Nat Rev Microbiol, 12(9), 635-645. https://doi.org/10.1038/nrmicro3330
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., Heath, A. C., Warner, B., Reeder, J., Kuczynski, J., Caporaso, J. G., Lozupone, C. A., Lauber, C., Clemente, J. C., Knights, D., . . . Gordon, J. I. (2012). Human gut microbiome viewed across age and geography. Nature, 486(7402), 222-227. https://doi.org/10.1038/nature11053
Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014). Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA, 312(17), 1772-1778. https://doi.org/10.1001/jama.2014.13875
Yutin, N., Benler, S., Shmakov, S. A., Wolf, Y. I., Tolstoy, I., Rayko, M., Antipov, D., Pevzner, P. A., & Koonin, E. V. (2021). Analysis of metagenome-assembled viral genomes from the human gut reveals diverse putative CrAss-like phages with unique genomic features. Nat Commun, 12(1), 1044. https://doi.org/10.1038/s41467-021-21350-w
Zboril, V. (2018). Idiopatické střevní záněty. Mlada Fronta
Zhang, F., Aschenbrenner, D., Yoo, J. Y., & Zuo, T. (2022). The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly. Lancet Microbe, 3(12), e969-e983. https://doi.org/10.1016/S2666-5247(22)00203-8
Zhang, F., Luo, W., Shi, Y., Fan, Z., & Ji, G. (2012). Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol, 107(11), 1755; author reply p 1755-1756. https://doi.org/10.1038/ajg.2012.251
Zheng, P., Li, Z., & Zhou, Z. (2018). Gut microbiome in type 1 diabetes: A comprehensive review. Diabetes Metab Res Rev, 34(7), e3043. https://doi.org/10.1002/dmrr.3043
Zhernakova, A., Kurilshikov, A., Bonder, M. J., Tigchelaar, E. F., Schirmer, M., Vatanen, T., Mujagic, Z., Vila, A. V., Falony, G., Vieira-Silva, S., Wang, J., Imhann, F., Brandsma, E., Jankipersadsing, S. A., Joossens, M., Cenit, M. C., Deelen, P., Swertz, M. A., LifeLines cohort, s., . . . Fu, J. (2016). Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science, 352(6285), 565-569. https://doi.org/10.1126/science.aad3369
Zhong, W., Lu, X., Shi, H., Zhao, G., Song, Y., Wang, Y., Zhang, J., Jin, Y., & Wang, S. (2019). Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis. J Clin Gastroenterol, 53(9), 660-672. https://doi.org/10.1097/MCG.0000000000000961
Zhou, Y., He, Y., Liu, L., Zhou, W., Wang, P., Hu, H., Nie, Y., & Chen, Y. (2021). Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases. Front Nutr, 8, 615064. https://doi.org/10.3389/fnut.2021.615064
Zuo, T., Wong, S. H., Lam, K., Lui, R., Cheung, K., Tang, W., Ching, J. Y. L., Chan, P. K. S., Chan, M. C. W., Wu, J. C. Y., Chan, F. K. L., Yu, J., Sung, J. J. Y., & Ng, S. C. (2018). Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome. Gut, 67(4), 634-643. https://doi.org/10.1136/gutjnl-2017-313952

 

Předběžná náplň práce

Cílem práce je zaměřit se na reakce střevního mikrobiomu na terapii pomocí longitudinálního sledování u celkem tří chronických střevních onemocnění: Crohnovy choroby (CD), celiakie (CeD) a syndromu dráždivého tračníku (IBS).

Předběžná náplň práce v anglickém jazyce

The aim of this study is to investigate the gut microbiome response to therapy using longitudinal monitoring in three chronic intestinal diseases: Crohn's disease (CD), celiac disease (CeD) and irritable bowel syndrome (IBS).